CRL 8-K 2026-11-04

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) 8-K dated 2026-11-04 — accession 0001100682-26-000156.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is a diagnostics & research company listed on US.

CRL to acquire platform ($245.6M)

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported CRL revenue for 2025-12-27 was $4.02B. Net income was -$144.3M. Revenue was down 0.9% from 2024-12-28 to 2025-12-27. CRL currently screens at market cap $7.78B.

Not investment advice. The CRL SEC hub lists recent forms. The stock page is the research view.